Azucena Mora, winner of the Syva Award 2003, achieves the highest academic level

As you know, we are always happy to share news of the award winners who have contributed to the prestige of the Syva Award for more than 27 years.

So, we are delighted to announce that on 13 September Azucena Mora successfully passed the contest for her appointment as Professor at the University of Santiago de Compostela in the area of Microbiology. This is the highest academic level that can be achieved. Her nomination takes place only 4 years after she was appointed as permanent professor in 2019.

It has been an impressive journey since 2003, when she submitted her thesis and, as a young doctor, won the Syva Award. Since then, her steps have regularly crossed those of our colleagues. Her testimony as a winner and as a member of the jury of the 25th edition of the Award in 2022 and today, her nomination as Professor, is a further source of pride for Syva and our entire team.

Through her career, her ever growing commitment to projects aimed at improving animal health and welfare, and her willingness to pass on knowledge, Azucena Mora has this precious power, as a mentor, to motivate younger generations of researchers. On behalf of the board and staff of Syva, we warmly congratulate her on this achievement and on her title.

We would also like to highlight, with great satisfaction, that three of the four professors who formed the Commission that assessed the chair have been part of our Syva Award panel in different editions (Ricardo de la Fuente, Rosa Caro, Luis Ortega and Ana Carvajal).

From left to right in the picture:

Ana Carvajal, Professor at the University of León, Ricardo de la Fuente, Professor at the Complutense University of Madrid, Rosa Caro, Professor at the University of Murcia, Azucena Mora, now professor at the University of Santiago de Compostela, Ana Otero, Professor at the University of Santiago de Compostela, Luis Ortega, Professor at the Complutense University of Madrid,

 

You may also be interested in

13 May, 2024

The day after the first vaccinations in the Netherlands, Syva organised a round table in Utrecht focusing on the situation of bluetongue in this country and its BTV-3 vaccine.

Among those taking part in the day, many technical and practical questions that were answered by our experts, some of which reflected both the concern of being confronted once again with this BTV3 epidemic and a form of joy and relief at knowing that at the very moment many animals were being vaccinated.

Read more

10 May, 2024

The Belgian federal medicines agency, FAMHP, has now also authorised the use of the BTV3 vaccine developed by the Syva laboratories.

We are pleased to announce that, while Dutch veterinarians began mass vaccination on Monday 6 May, the Belgian veterinary health authorities on Wednesday 8 May authorised the use of Laboratories Syva's BTV3 vaccine under Article 110(2) of Regulation (EU) 2019/6.

Read more

26 April, 2024

Dutch authorities approved the use of the vaccine against bluetongue serotype 3 developed by Laboratorios Syva

After intensive work performed by our teams in our laboratories, an excellent coordination with the contract research organisations (CRO) which carried out the clinical trials necessary to test the vaccine's safety and efficacy, and an efficient communication with the authorities in the Netherlands, Syva Laboratories is pleased to announce that its vaccine against BTV 3 has been authorised for...

Read more